当前位置:首页 - 行情中心 - 安图生物(603658) - 财务分析 - 资产负债表

安图生物

(603658)

  

流通市值:334.12亿  总市值:334.12亿
流通股本:5.86亿   总股本:5.86亿

资产负债表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
流动资产:
货币资金443,065,646.47471,621,976.22729,414,672.471,137,621,764.53
应收票据及应收账款1,160,225,944.641,094,965,839.451,033,025,149.221,074,176,100.51
其中:应收票据50,603,552.8236,700,292.3134,553,100.4221,736,966.33
应收账款1,109,622,391.821,058,265,547.14998,472,048.81,052,439,134.18
应收款项融资1,933,6983,337,2961,561,239.6269,139.8
预付款项61,737,835.0353,449,757.3151,065,51276,844,314.35
其他应收款合计30,051,210.9336,067,830.0843,160,658.9627,724,176.49
应收股利350,450.28369,919.74369,919.74369,919.74
存货748,795,765.35725,934,276.16687,571,655.26752,303,140.17
其他流动资产3,934,718,129.983,704,169,244.543,552,937,090.063,184,609,065.62
流动资产平衡项目0000
流动资产合计6,380,528,230.46,089,546,219.766,098,735,977.576,253,547,701.47
非流动资产:
长期股权投资8,195,5099,285,36910,667,902.8710,755,004.86
其他权益工具投资105,883,561.543,000,00043,000,0003,000,000
投资性房地产2,809,236.562,845,798.832,882,361.112,918,923.38
固定资产1,916,193,969.561,933,379,529.31,962,327,468.71,987,379,238.16
在建工程1,679,269,588.991,550,740,123.591,445,945,604.671,272,452,708.18
使用权资产36,621,539.0225,710,905.2429,375,777.2332,988,906.35
无形资产184,268,774.91189,903,926.76197,595,530.58203,265,333.96
商誉164,648,504.26164,648,504.26164,648,504.26164,648,504.26
长期待摊费用59,574,918.0861,659,554.9769,000,990.6369,195,671.9
递延所得税资产275,265,559.6262,217,300.72252,921,374.23238,729,041.78
其他非流动资产258,960,516.51247,267,018.92235,271,064233,438,038.72
非流动资产平衡项目0000
非流动资产合计4,691,691,677.994,490,658,031.594,413,636,578.284,218,771,371.55
资产平衡项目0000
资产总计11,072,219,908.3910,580,204,251.3510,512,372,555.8510,472,319,073.02
流动负债:
短期借款300,200,694.44200,106,944.44175,048,888.81100,085,555.53
交易性金融负债--20,000-
应付票据及应付账款722,989,642.54750,140,155.63716,172,415.491,010,297,340.11
其中:应付票据457,000,000479,000,000439,000,000714,000,000
应付账款265,989,642.54271,140,155.63277,172,415.49296,297,340.11
合同负债59,938,697.3859,987,316.1559,842,436.784,232,486.75
应付职工薪酬103,081,700.9777,915,396.5339,344,154.17192,537,690.02
应交税费117,571,384.62100,587,405124,006,130.51129,815,997.2
其他应付款合计541,899,885.05545,596,177.24558,718,712.87556,735,071.53
一年内到期的非流动负债308,187,831.11307,596,102.6275,424,873.0516,198,597.13
其他流动负债117,897,189.93100,404,580.4891,379,337.5276,953,605.65
流动负债平衡项目0000
流动负债合计2,271,767,026.042,142,334,078.091,839,956,949.122,166,856,343.92
非流动负债:
长期借款55,043,541.6855,031,666.67115,074,555.55-
租赁负债24,477,574.7814,050,795.2917,395,027.9416,259,177.8
预计负债2,369,271.462,422,223.255,309,473.982,224,686.07
递延收益22,780,002.3129,202,791.9333,412,635.8130,815,087.24
递延所得税负债257,834,269.68262,453,892.53266,078,360.5273,033,047.91
其他非流动负债79,988,691.476,830,086.375,912,720.2170,950,142.03
非流动负债平衡项目0000
非流动负债合计442,493,351.31439,991,455.97513,182,773.99393,282,141.05
负债平衡项目0000
负债合计2,714,260,377.352,582,325,534.062,353,139,723.112,560,138,484.97
所有者权益(或股东权益):
实收资本(或股本)586,272,256586,272,256586,272,256586,272,256
资本公积4,100,916,401.244,100,916,401.244,100,916,401.244,100,916,401.24
减:库存股243,300,008.68243,300,008.68243,300,008.68243,300,008.68
其他综合收益1,193,331.111,221,782.43485,155.65605,789.18
盈余公积293,162,011.78293,162,011.78293,162,011.78293,162,011.78
未分配利润3,481,047,161.613,125,999,797.643,287,005,763.533,044,935,852.78
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计8,219,291,153.067,864,272,240.418,024,541,579.527,782,592,302.3
少数股东权益138,668,377.98133,606,476.88134,691,253.22129,588,285.75
股东权益平衡项目0000
股东权益合计8,357,959,531.047,997,878,717.298,159,232,832.747,912,180,588.05
负债和股东权益合计11,072,219,908.3910,580,204,251.3510,512,372,555.8510,472,319,073.02
公告日期2023-10-262023-08-182023-04-212023-04-21
审计意见(境内)标准无保留意见
TOP↑